Cavan M. Redmond - 16 Mar 2022 Form 4 Insider Report for Oncocyte Corp (OCX)

Role
Director
Signature
/s/ Cavan Redmond
Issuer symbol
OCX
Transactions as of
16 Mar 2022
Net transactions value
+$47,560
Form type
4
Filing time
16 Mar 2022, 21:08:51 UTC
Previous filing
28 Jun 2021
Next filing
19 Jul 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCX Common Stock, no par value Purchase $47,560 +40,000 +56% $1.19 110,863 16 Mar 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.